Array Biopharma Inc ARRY shares are trading higher by $1.16 (10 percent) at $11.86 in Thursday's session. Before the open, the company announced a Q4 EPS beat of $0.04 along with a $15.23 million beat for sales.
After a higher open, it retreated but found support just ahead of Wednesday's close ($10.70) only reaching $10.81 before continuing its move higher. So far, the ensuing rally has taken the issue to $12.08, but has fallen back into the $11.00 handle.
This marks the highest level for the issue since December 2007 when it peaked at $12.45, but faltered to end that year at $8.42.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.